12:00 AM
 | 
Sep 08, 2011
 |  BC Innovations  |  Distillery Therapeutics

Indication: Various

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Various
Diabetes Peroxisome proliferation-activated receptor-g (PPARG; PPARg); cyclin dependent kinase 5 (CDK5) In vitro and mouse studies identified PPARg-binding compounds...

Read the full 229 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >